A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
The primary objective of this study is to assess the efficacy of fostamatinib in subjects with warm antibody autoimmune hemolytic anemia (wAIHA).
Inclusion Criteria:
Exclusion Criteria:
Greeley, Colorado 80538, United States
Washington D.C., District of Columbia 20007, United States
Pleven, 5800, Bulgaria
Sofia, 1431, Bulgaria
Sofia, 1431, Bulgaria
Sofia, 1756, Bulgaria
Varna, 9010, Bulgaria
Pessac, 33603, France
Leipzig, 04103, Germany
Budapest, 1083, Hungary
Nyíregyháza, 4400, Hungary
Pécs, 7624, Hungary
Milan, 20122, Italy
Trieste, 34125, Italy
Novosibirsk, Russian Federation 630051, Russia
Moscow, 129301, Russia
Sochi, 354057, Russia
Tomsk, 634063, Russia
Belgrade, 11080, Serbia
Liverpool, L7 8XP, United Kingdom